Sorafenib 200 Drl 200 mg Fim-coated tablets
PDF Leaflet Revision Date: 08 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Advanced renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid carcinoma.
Dosage (summary)
400 mg daily (2 x 200 mg tablets) taken twice daily.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; avoid breastfeeding during treatment.
Key Drug Interactions
- Warfarin
- Docetaxel
- Neomycin
Contraindications
- Severe hypersensitivity to sorafenib
- Pregnancy
- Lactation
Common side effects
- Diarrhoea
- Fatigue
- Alopecia
- Hand-foot skin reaction
- Rash
Counselling Points
- Monitor blood pressure regularly
- Report any signs of bleeding
- Use effective contraception during treatment
Serious warnings
- Hypertension
- Cardiac ischaemia/infarction
- Gastrointestinal perforation
- QT prolongation
Important Disclaimer
The Sorafenib 200 Drl 200 mg Fim-coated tablets professional information leaflet below is the property of Dr ReddyãS Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
